kabutan
N225

67,005.87

-2.54%

TOPIX

4,044.86

-1.06%

USDJPY

162.13

-0.04%

CREATE MEDIC, First Half Ordinary Profit Increases by 52%

Tue Aug 5, 2025 11:30 am JST Earnings

5187 CREATE MEDIC CO.,LTD. 【J-GAAP】

Earnings Report

CREATE MEDIC CO.,LTD. <5187> [TSE Std] announced its financial results at noon (11:30) on August 5th. The consolidated ordinary profit for the cumulative second quarter of the fiscal year ending December 2025 (January to June) expanded 0.52 billion yen, an increase 52.2% compared to the same period last year, exceeded the previous forecast of 0.35 billion yen.

Progress toward the full-year plan of 1.04 billion yen was 50.3%, almost the same as the five-year average of 47.6%.

Based on the first-half performance announced by the company and the unchanged full-year plan, our calculation indicates that the consolidated ordinary profit for the July to December period (second half) is expected to grow 27.9% from the same period last year, reaching 0.51 billion yen.

In the most recent three-month period, from April to June (2Q), the consolidated ordinary profit grew 29.7% from the same period last year, reaching 0.31 billion yen. The operating profit margin significantly improved from 5.8% in the same period last year to 9.8%.

Kabutan News

Actual Performance and Financial Trends

Accumulated Results 2nd Quarter
Fiscal Year Revenue Operating
Profit
Ordinary
Profit
Net
Profit
Adj.
EPS
Progress Rate
vs. First Half
Announce Accounting
Standards
Jan - Jun, 2023
6,025M 335M 371M 316M 34.8 42.5 Aug 4, 2023 J-GAAP
Jan - Jun, 2024
6,300M 291M 345M 550M 61.4 46.0 Aug 5, 2024 J-GAAP
Jan - Jun, 2025
6,564M 548M 525M 412M 48.4 50.3 Aug 5, 2025 J-GAAP
YoY +4.2% +88.3% +52.2% -25.1% -21.2%
First Half Results vs. Previous Guidance
Fiscal Year Revenue Operating
Profit
Ordinary
Profit
Net
Profit
Adj.
EPS
Adj.
Dividend
Announce Accounting
Standards
Jan - Jun, 2025 Guidance 6,397M 309M 352M 192M 22.6 17 Feb 13, 2025 J-GAAP
Jan - Jun, 2025 Results 6,564M 548M 525M 412M 48.4 17 Aug 5, 2025 J-GAAP
Revision Rate +2.6% +77.3% +49.1% +114.6% +113.7%

Current Period Guidance

Second Half Results
Fiscal Year Revenue Operating
Profit
Ordinary
Profit
Net
Profit
Adj.
EPS
Adj.
Dividend
Announce Accounting
Standards
Jul - Dec, 2024
6,730M 401M 405M 290M 32.9 20 Feb 13, 2025 J-GAAP
Guidance
Jul - Dec, 2025
7,019M 454M 518M 384M 45.8 20 Aug 5, 2025 J-GAAP
YoY +4.3% +13.2% +27.9% +32.4% +39.0%
Current Period Guidance
Fiscal Year Revenue Operating
Profit
Ordinary
Profit
Net
Profit
Adj.
EPS
Adj.
Dividend
Announce Accounting
Standards
Dec, 2023
12,585M 803M 872M 154M 16.9 37 Feb 14, 2024 J-GAAP
Dec, 2024
13,030M 692M 750M 840M 95.4 39 Feb 13, 2025 J-GAAP
Guidance
Dec, 2025
13,583M 1,002M 1,043M 796M 94.9 37 Feb 13, 2025 J-GAAP
YoY +4.2% +44.8% +39.1% -5.2% -0.5%

Quarterly Results

Fiscal Year Revenue Operating
Profit
Ordinary
Profit
Net
Profit
Adj.
EPS
Operating
Profit Margin
Announce Accounting
Standards
Apr - Jun, 2024
3,324M 193M 239M 491M 54.8 5.8 Aug 5, 2024 J-GAAP
Jul - Sep, 2024
3,212M 230M 200M 194M 21.9 7.2 Oct 31, 2024 J-GAAP
Oct - Dec, 2024
3,518M 171M 205M 96M 10.9 4.9 Feb 13, 2025 J-GAAP
Jan - Mar, 2025
3,220M 221M 215M 209M 24.4 6.9 May 7, 2025 J-GAAP
Apr - Jun, 2025
3,344M 327M 310M 203M 23.8 9.8 Aug 5, 2025 J-GAAP
YoY +0.6% +69.4% +29.7% -58.7% -56.5%